Evidence map›Paper›PMID 27611840›Full record

ArticlePloS one2016

In Vivo Imaging Demonstrates That Borrelia burgdorferi ospC Is Uniquely Expressed Temporally and Spatially throughout Experimental Infection.

Jonathan T Skare, Dana K Shaw, Jerome P Trzeciakowski, Jenny A Hyde

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Infection and immunity · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Genetic Manipulation ofCurrent issues in molecular biology · 2021
    Review
  8. Immune Response toCurrent issues in molecular biology · 2021
    Article
  9. Lyme Disease in Humans.Current issues in molecular biology · 2021
    Article
  10. Live Imaging.Current issues in molecular biology · 2021
    Review
  11. Lyme Disease Pathogenesis.Current issues in molecular biology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Lyme Disease Frontiers: ReconcilingPathogens (Basel, Switzerland) · 2019
    Review
  16. The RpoS Gatekeeper inFrontiers in microbiology · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. A Dual Luciferase Reporter System forFrontiers in cellular and infection microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jonathan T SkareDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Bryan/College Station, Texas, United States of America.
Dana K ShawDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Bryan/College Station, Texas, United States of America.
Jerome P TrzeciakowskiDepartment of Medical Physiology, College of Medicine, Texas A&M Health Science Center, Bryan/College Station, Texas, United States of America.
Jenny A HydeDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Bryan/College Station, Texas, United States of America.ORCID http://orcid.org/0000-0001-9442-9980
Texas A&M Health Science Center · US

Funding

In vivo dual Bioluminescence Reporter System of Infectious Borrelia burgdorferiR21AI101740 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HYDE, JENNY A. · 2012 to 2013
$388k
NIAID NIH HHS R21 AI101740
6 · The paper itself

Abstract

Borrelia burgdorferi is a spirochetal bacterium transmitted by the Ixodes tick that causes Lyme disease in humans due to its ability to evade the host immune response and disseminate to multiple immunoprotective tissues. The pathogen undergoes dynamic genetic alterations important for adaptation from the tick vector to the mammalian host, but little is known regarding the changes at the transcriptional level within the distal tissues they colonize. In this study, B. burgdorferi infection and gene expression of the essential virulence determinant ospC was quantitatively monitored in a spatial and temporal manner utilizing reporter bioluminescent borrelial strains with in vivo and ex vivo imaging. Although expressed from a shuttle vector, the PospC-luc construct exhibited a similar expression pattern relative to native ospC. Bacterial burden in skin, inguinal lymph node, heart, bladder and tibiotarsal joint varied between tissues and fluctuated over the course of infection possibly in response to unique cues of each microenvironment. Expression of ospC, when normalized for changes in bacterial load, presented unique profiles in murine tissues at different time points. The inguinal lymph node was infected with a significant B. burgdorferi burden, but showed minimal ospC expression. B. burgdorferi infected skin and heart induced expression of ospC early during infection while the bladder and tibiotarsal joint continued to display PospC driven luminescence throughout the 21 day time course. Localized skin borrelial burden increased dramatically in the first 96 hours following inoculation, which was not paralleled with an increase in ospC expression, despite the requirement of ospC for dermal colonization. Quantitation of bioluminescence representing ospC expression in individual tissues was validated by qRT-PCR of the native ospC transcript. Taken together, the temporal regulation of ospC expression in distal tissues suggests a role for this virulence determinant beyond early infection.

Indexed as

Analysis of VarianceAnimalsBacterial ProteinsBlotting, WesternBorrelia burgdorferiFemaleLuminescent MeasurementsMiceMice, Inbred BALB CReverse Transcriptase Polymerase Chain ReactionBacterial Proteins

Identifiers

PMID27611840
PMCPMC5017786
OpenAlexW2518630972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.